WallStreetZenWallStreetZen

NASDAQ: ADXN
Addex Therapeutics Ltd Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Addex Therapeutics earnings were -$8.6M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest ADXN earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$2.2M, down 5.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ADXN reported annual earnings of -$8.5M, with -208.6% growth.

ADXN earnings history

Current Revenue
$140.4k
Current Earnings
-$8.9M
Current Profit Margin
-6,362.9%

ADXN Return on Equity

Current Company
-131.3%
Current Industry
-141.9%
Current Market
13.5%
ADXN's Return on Equity (-131.3%)... subscribe to Premium to read more.
High Return on Equity Performance

ADXN Return on Assets

Current Company
-103.4%
Current Industry
-13.7%
ADXN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ADXN announces earnings.

ADXN Return on Capital Employed

Current Company
-197.01%
Current Industry
-9.6%
ADXN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ADXN vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ADXN-$8.58M-$8.60MN/A-$0.06
RNAZ-$39.81M-$43.70MN/A-$50.33
EVGN-$5.64M-$11.77MN/A-$1.45
BCAB-$50.31M-$50.62MN/A-$41.22
INM-$7.91M-$8.51MN/A-$2.11
View Top Biotech Stocks

Addex Therapeutics Earnings Reports & History FAQ

What were Addex Therapeutics's earnings last quarter?

On ADXN's earnings call on Jun 25, 2026, Addex Therapeutics (NASDAQ: ADXN) reported Q1 2026 earnings per share (EPS) of -$0.01, up 18.18% year over year. Total ADXN earnings for the quarter were -$2.19 million. In the same quarter last year, Addex Therapeutics's earnings per share (EPS) was -$0.01.

If you're new to stock investing, here's how to buy Addex Therapeutics stock.

Is Addex Therapeutics profitable or losing money?

As of the last Addex Therapeutics earnings report, Addex Therapeutics is currently losing money. Addex Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$8.93 million, a 190.66% decrease year over year.

What was ADXN's earnings growth in the past year?

As of Addex Therapeutics's earnings date in Jun 25, 2026, Addex Therapeutics's earnings has grown year over year. ADXN earnings in the past year totalled -$8.60 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.